CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 471851754
- Phone
- 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 7,624 shares at $10.03 ($76,469)
- 4 Planned sale Chief Executive Officer sold 7,734 shares at $10.02 ($77,495)
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Chief Technology Officer gave up 234 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,901 shares (to pay taxes)
- 8-K Event Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- 4 Shares withheld for taxes Chief Strategy & Legal Officer gave up 4,699 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,701 shares (to pay taxes)
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Grant or award Director acquired 7,768 shares (grant or award)
Page 5 of 41 · 806 filings